CONSHOHOCKEN, Pa., Feb. 25, 2026 /PRNewswire/ -- Suvoda, a clinical trial technology company, today announced new split budget functionality within its Budgeting & Benchmarking solution, expanding how ...
Please provide your email address to receive an email when new articles are posted on . Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative ...
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical TM solution, a software-as-a-service (SaaS), end-to-end clinical data ...
Medable is taking its digital clinical trial platform to new heights: the Google Cloud Marketplace. Through the collaboration, Google Cloud’s infrastructure and AI features will be integrated into ...
In this Q&A article with the Eye Care Network, Daniela Ferrara, MD, PhD, FASRS, FARVO, discusses the role of low- and middle-income country (LMIC) data in informing US ophthalmology clinical trials, ...
Joseph M. Coney, MD, FACS, discusses the importance of diverse representation in clinical trials for the ongoing advancement of safe and effective treatments, and underscores the need for cultivating ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--NVISION Eye Centers, a national leader in eye care services, is excited to announce that its subsidiary, NVision Clinical Research, LLC., and Parkhurst NuVision, ...
Joseph M. Coney, MD, FACS, discusses the crucial role of ongoing community support and active engagement in boosting clinical trial recruitment and emphasizes the importance of establishing trust and ...
Please provide your email address to receive an email when new articles are posted on . ROME — The total estimated costs from inherited retinal diseases in the United States amounts to $31.8 billion.
In July 2025, 3 4DMT announced its intent to accelerate its 4D-150 4FRONT phase 3 program in wet AMD and lay off approximately 25% of staff. 4DMT noted that this transition supported the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results